The gemcitabine/epirubicin/paclitaxel trials in advanced breast cancer.
2001
Capecitabine (Xeloda) is the first orally available fluoropyrimidine approved for use in patients with cancer. It was initially approved for use in metastatic breast cancer, but significant data also support its use in the management
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
23
References
36
Citations
NaN
KQI